Inner Cosmos Appoints John Freund to Board of Directors and Greg Schulte as Advisory CTO to Advance Psychiatric BCI for Depression
Inner Cosmos Inner Cosmos, a neurotechnology company pioneering psychiatric treatment with a minimally invasive BCI for refractory depression, today announced […]
